These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6674806)

  • 1. [Experimental study of the modified human saphenous vein as a small caliber arterial substitute].
    Uemura S
    Nihon Geka Gakkai Zasshi; 1983 May; 84(5):452-64. PubMed ID: 6674806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental studies on modified human ureter as an arterial substitution for reconstruction of small caliber vessels.
    Uematsu M; Okada M
    Kobe J Med Sci; 1996 Oct; 42(5):291-306. PubMed ID: 9153968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of glutaraldehyde-tanning on the elasticity of the human saphenous vein.
    Harjula A; Mattila S
    Ann Chir Gynaecol; 1980; 69(2):60-4. PubMed ID: 6769380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutaraldehyde pre-treated human saphenous and umbilical veins as xenogeneic small vessel substitutes and shunts in dogs.
    Harjula A
    Ann Chir Gynaecol; 1981; 70(1):11-7. PubMed ID: 7259055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of saphenous vein graft from arterial pressure: an experimental study.
    Kurdal AT; Ustundag N; Güven A; Iskesen I; Bozkurt K; Sirin BH
    Thorac Cardiovasc Surg; 2009 Sep; 57(6):333-8. PubMed ID: 19707974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic findings after in vivo placement of small intestine submucosal vascular grafts and saphenous vein grafts in the carotid artery in dogs.
    Sandusky GE; Badylak SF; Morff RJ; Johnson WD; Lantz G
    Am J Pathol; 1992 Feb; 140(2):317-24. PubMed ID: 1739125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of modified human umbilical vein as an arterial substitute in femoropopliteal reconstructive surgical procedures.
    Lee BY; Trainor FS; Kavner D; McCann WJ
    Surg Gynecol Obstet; 1978 Nov; 147(5):721-5. PubMed ID: 102043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Why and when to preserve the saphenous veins of varicose patients to serve as an arterial bypass?].
    Mellière D
    J Mal Vasc; 1994; 19(3):216-21. PubMed ID: 7798809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-engineered blood vessel graft produced by self-derived cells and allogenic acellular matrix: a functional performance and histologic study.
    Yang D; Guo T; Nie C; Morris SF
    Ann Plast Surg; 2009 Mar; 62(3):297-303. PubMed ID: 19240529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The factors influencing early patency of coronary artery bypass vein grafts: correlation of angiographic and ultrastructural findings.
    Catinella FP; Cunningham JN; Srungaram RK; Baumann FG; Nathan IM; Glassman EA; Knopp EA; Spencer FC
    J Thorac Cardiovasc Surg; 1982 May; 83(5):686-700. PubMed ID: 6978974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological study of flow surface of glutaraldehyde pre-treated vascular substitutes.
    Harjula A; Myllärniemi H; Nickels J; Mattila S
    Ann Chir Gynaecol; 1980; 69(4):144-50. PubMed ID: 7469366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on the elastic properties of vascular prostheses].
    Sakuma M
    Nihon Geka Gakkai Zasshi; 1987 May; 88(5):613-21. PubMed ID: 3600596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aorta-coronary bypass grafting with heparinized vascular grafts in dogs. A preliminary study.
    Nojiri C; Noishiki Y; Koyanagi H
    J Thorac Cardiovasc Surg; 1987 Jun; 93(6):867-77. PubMed ID: 3494887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preserved human umbilical cord vessel as a small caliber vascular substitute: experimental and clinical study].
    Sasajima T
    Nihon Geka Gakkai Zasshi; 1984 Jan; 85(1):65-76. PubMed ID: 6429517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collagen subtype pattern in normal and varicose saphenous veins in humans.
    Waksman Y; Mashiah A; Hod I; Rose SS; Friedman A
    Isr J Med Sci; 1997 Feb; 33(2):81-6. PubMed ID: 9254867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prejudices and realities in the use of 'unsuitable' saphenous vein graft for infrapopliteal revascularization.
    Siani A; Accrocca F; Antonelli R; Giordano GA; Gabrielli R; Siani LM; Baldassarre E; Mounyergi F; Marcucci G
    G Chir; 2008; 29(6-7):261-4. PubMed ID: 18544261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of aneurysm formation in vascular grafts of biologic origin.
    Hamilton G; Megerman J; L'Italien GJ; Warnock DF; Schmitz-Rixen T; Brewster DC; Abbott WM
    J Vasc Surg; 1988 Mar; 7(3):400-8. PubMed ID: 2831410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of wall mechanical properties on patency of arterial grafts.
    Kidson IG
    Ann R Coll Surg Engl; 1983 Jan; 65(1):24-9. PubMed ID: 6218775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
    Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of intimal hyperplasia by single-dose pre-insertion external radiation in canine-vein interposition grafts.
    Ulus AT; Tütün U; Zorlu F; Can C; Apaydin N; Karacagil S; Katircioğlu SF; Bayazit M
    Eur J Vasc Endovasc Surg; 2000 May; 19(5):456-60. PubMed ID: 10828224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.